Yonghe Medical: Turned profitable in 2025 with a net profit of 73.6 million yuan, owning 63 hair transplant medical institutions across 61 cities nationwide.

LightningPacketLoss · 2026-04-01T10:35:57+00:00

Yonghe Medical released its 2025 annual performance announcement on March 31, with revenue of 1.808 billion yuan, a year-on-year increase of 0.2%; gross profit of 1.194 billion yuan, with a gross profit margin rising to 66.0%. Hair transplant service revenue accounted for 76.1%, and the number of consumers increased to 71,380. The company has 63 medical institutions across 61 cities.

LightningPacketLoss

2026-04-01 10:35:57

Abstract generation in progress

On March 31, 2025, Yonghe Medical released its annual results announcement for the year ended December 31, 2025. The company’s 2025 revenue was 1.808 billion yuan, up 0.2% year over year; gross profit was 1.194 billion yuan, up 10.1%, with the gross margin increasing from 60.1% in 2024 to 66.0%; net profit was 73.6 million yuan, compared with a loss of 227 million yuan in 2024.

In the Management Discussion and Analysis section, the company stated that its hair transplant medical services business generated revenue of 1.375 billion yuan, accounting for 76.1% of total revenue. The number of consumers receiving hair transplant medical services increased from 59,655 in 2024 to 71,380 in 2025. During the reporting period, the company also significantly improved overall operating efficiency and customer satisfaction by optimizing its store network and enhancing management efficiency.

The announcement noted that, as of December 31, 2025, the company had 63 hair transplant medical institutions in 61 cities nationwide. In Shenzhen, Shanghai, and Guangzhou, it has 7 Shiyunxun Jianfa institutions, serving more than 120,000 consumers in total.

(Yonghe Medical announcement)

(Editor: Yang Yan, Lin Chen)

Keywords:

                                                            Medical

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes